Brette L. Trost
Lawyers
Associate in our IP & Tech Transactions practice. Previously completed a rotation in Mergers & Acquisitions.
Experience highlights
Recent Representations
- HilleVax $200 million IPO
- SPX FLOW $500 million senior notes offering
- Shiseido transfer of Professional business to Henkel
- Ankura Consulting Group acquisition of Noragh Analytics
- Convey Health Solutions acquisition of HealthSmart International
- Biodesix $50 million at-the-market offering
- First Advantage $345 million secondary offering
- TaskUs upsized $766.9 million follow-on offering
- Nuvei $425 million U.S. IPO
- Genesis Capital sale to New Residential Investment
- Thoughtworks Holding $889.7 million IPO
- SOPHiA GENETICS $234 million IPO and $20 million private placement
- ChargePoint Holdings $282 million secondary offering
- First Advantage $439.9 million IPO
- Century Therapeutics $242.7 million IPO
- Codere Online business combination with DD3 Acquisition Corp. II
Education
J.D., New York University School of Law
- Order of the Coif
- magna cum laude
- Managing Editor, New York University Journal of Intellectual Property & Entertainment Law
B.A., English, University of Pennsylvania
- summa cum laude
Professional history
- Davis Polk since 2019
Qualifications and admissions
- State of New York